Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis

Journal of Medical Investigation

Volumn 46, Issue 3-4, 1999, Pages 151-158

  Kohno, Nobuoki ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interstitial pneumonitis; KL 6; KL 6 MUC1; Serum marker

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CA 15-3 ANTIGEN; GLYCOPROTEIN; MUC1 MUCIN PEPTIDE; MUC1 PROTEIN, HUMAN; MUCIN; PEPTIDE FRAGMENT; TUMOR ANTIGEN;

ANIMAL; BLOOD; CHEMISTRY; DISEASE MANAGEMENT; HUMAN; INTERSTITIAL LUNG DISEASE; METABOLISM; REVIEW;

ANIMALS; ANTIGENS; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CA-15-3 ANTIGEN; DISEASE MANAGEMENT; GLYCOPROTEINS; HUMANS; LUNG DISEASES, INTERSTITIAL; MUCINS; PEPTIDE FRAGMENTS;

EID: 0033169890     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. rd ed. B.C. Decker Inc, Hamilton, pp3-30
2. Wells AU, du Bois RM : Prediction of disease progression in idiopathic pulmonary fibrosis. Eur Respir J 7 : 637-639, 1994
3. Bensard DD, McIntyre RC Jr, Waring BJ, Simon JS : Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 103 : 765-770, 1993
4. Katzenstein AL, Myers JL : Idiopathic pulmonary fibrosis : clinical relevance of pathologic classification. Am J Respir Crit Care Med 157 : 1301-15, 1998
5. Leung AN, Miller RR, Muller NL: Parenchymal opacification in chronic infiltrative lung diseases : CT-pathologic correlation. Radiology 188 : 209-214, 1993
6. Watters LC, Schwarz MI, Cherniack RM, Waldron JA, Dunn TL, Stanford RE, King TE : Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 135 : 696-704, 1987
7. Agusti C, Xaubet A, Agusti AG, Roca J, Ramirez J, Rodriguez-Roisin R : Clinical and functional assessment of patients with idiopathic pulmonary fibrosis : results of a 3 year follow-up. Eur Respir J 7 : 643-650, 1994
8. Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, du Bois RM : Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 6 : 797-802, 1993
9. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M : Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18 : 203-216, 1988
10. Stahel RA, Gilks WR, Lehmann H-P, Schenker T : Third international workshop on lung tumor and differentiation antigens : overview of the results of the central data analysis. Int J Cancer Suppl 8 : 6-26, 1994
11. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M : New serum indicator of interstitial pneumonitis activity : sialylated carbohydrate antigen KL-6. Chest 96 : 68-73, 1989
12. Hamada H, Kohno N, Akiyama M, Hiwada K : Monitoring of serum KL-6 antigen in a patient with radiation pneumonia. Chest 101 : 858-860, 1992
13. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M : Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102 : 117-122, 1992
14. Kohno N, Inoue Y, Hamada H, Fujioka S, Fujino S, Yokoyama A, Hiwada K, Ueda N, Akiyama M : Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer Suppl. 8 : 81-83, 1994
15. Kobayashi J, Kitamura S : KL-6 : a serum marker for interstitial pneumonia. Chest 108 : 311-315, 1995
16. Kobayashi J, Kitamura S : Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 109 : 1276-1282, 1996
17. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J : Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129 : 255-265, 1995
18. Wesseling J, van der Valk SW, Hilkens J : A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7 : 565-577, 1996
19. Guddo F, Giatromanolaki A, Patriarca C, Hilkens J, Reina C, Alfano RM, Vignola AM, Koukourakis MI, Gambacorta M, Pruneri G, Coggi G, Bonsignore G : Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progression. Anticancer Res 18: 1915-20, 1998
20. Kondo K, Kohno N, Yokoyama A, Hiwada K : Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 58 : 2014-2019, 1998
21. Guddo F, Giatromanolaki A, Koukourakis MI, Reina C, Vignola AM, Chlouverakis G, Hilkens J, Gatter KC, Harris AL, Bonsignore G : MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. J Clin Pathol 51: 667-671, 1998
22. Sagara M, Yonezawa S, Nagata K, Tezuka Y, Natsugoe S, Xing PX, McKenzie IF, Aikou T, Sato E : Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma : its relationship with prognosis. Int J Cancer 84: 251-257, 1999
23. Hiraga Y, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N : Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 55 : 307-319, 1998
24. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E : Expression of MUC1 and MUC2 mucins in gastric carcinomas : its relationship with the prognosis of the patients. Clin Cancer Res 4 : 2605-2614, 1998
25. Aoki R, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N : MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma. Dis Colon Rectum 41 : 1262-1272, 1998
26. Tanimoto T, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N : MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression. Oncology 56 : 223-231, 1999
27. Zhang K, Baeckstrom D, Brevinge H, Hansson GC : Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 60 : 538-549, 1996
28. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K : KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 17 : 501-507, 1997
29. Nakajima M, Manabe T, Niki Y, Matsushima T : Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis. Thorax 53 : 809-811, 1998
30. Takahashi T, Munakata M, Suzuki I, Kawakami Y : Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 158 : 1294-1298, 1998
31. Inoue Y, Nishimura K, Shiode M, Akutsu H, Hamada H, Fujioka S, Fujino S, Yokoyama A, Kohno N, Hiwada K : Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis. Tuber Lung Dis 76 : 230-233, 1995
32. DeRemee RA : Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 204 : 1193-1195, 1968
33. Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS : Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 156 : 109-115, 1997
34. Koshimizu N, Satoh J, Tsukamoto K, Todate A, Toyoshima M, Segawa S, Hayakawa K, Chida K, Satoh A : The clinical usefulness of KL-6 in the evaluation of disease activity of idiopathic interstitial pneumonia. Nippon Kyobu Shikkan Gakkai Zasshi 34 Suppl : A189, 1996 (in Japanese)
35. Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, Hirasawa Y, Hiwada K : Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care 158 : 1680-1684, 1998
36. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K : KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 148 : 637-642, 1993
37. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB : Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J Clin Invest 78 : 1513-1522, 1986
38. Hansson L, Folkesson HG, Andersson R, Jeppsson B, Holst E, Westrom BR, Ahren B : Increased passage of bovine serum albumin over the respiratory tract after intratracheal instillation during septic shock in rats. Eur Surg Res 24 : 45-53, 1992
39. Shiota Y, Furuya K, Kitade M, Ueda N : CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia. Nippon Kyobu Shikkan Gakkai Zasshi 27 : 887-893, 1989 (in Japanese)
40. Fujita J, Obayashi Y, Yamadori I, Ohtsuki Y, Miyawaki H, Hojo S, Furukawa Y, Takahara J : Marked elevation of CA 19-9 in a patient with idiopathic pulmonary fibrosis : CA19-9 as a bad prognostic factor. Respirology 3 : 211-214, 1998
41. Satoh H, Kamma H, Ogata T, Yano H, Ohtsuka M, Hasegawa S : Clinical significance of serum levels of a carbohydrate antigen, sialyl SSEA-1, in patients with fibrosing lung disease. Am Rev Respir Dis 144 : 1177-1181, 1991
42. Mukae H, Hirota M, Kohno S, Komori K, Fukushima K, Hiratani K, Kadota J, Hara K : Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 148 : 744-751, 1993
43. Yokoyama A, Kohno N, Kondo K, Ueda S, Hirasawa Y, Watanabe K, Takada Y, Hiwada K : Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia. Respirology 3 : 199-202, 1998
44. Kirk JM, Bateman ED, Haslam PL, Laurent GJ, Turner-Warwick M : Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax 39 : 726-732, 1984
45. Tamura A, Matsubara O, Akagawa S, Nagai H, Kurashima A, Yoshimura N, Ichioka M, Kasuga T : Serum 7S collagen levels in diffuse interstitial lung diseases - an index of the destruction of alveolar structure. Nippon Kyobu Shikkan Gakkai Zasshi 30 : 2089-2097, 1992 (in Japanese)
46. Kohno N, Yokoyama A, Hirasawa Y, Kondo K, Fujino S, Abe M, Hiwada K : Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia. Respir Med 91 : 558-561, 1997
47. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K : Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis : association with pulmonary fibrosis. J Rheumatol 24 : 663-665, 1997
48. Kadono T, Kikuchi K, Kubo M, Fujimoto M, Tamaki K : Serum concentrations of basic fibroblast growth factor in collagen diseases. J Am Acad Dermatol 35 : 392-397, 1996
49. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT: Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89 : 5371-5375, 1992
50. Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, Takahashi K : Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 25 : 455-463, 1994
51. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, Muller-Quernheim J : Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 157 : 762-768, 1998
52. Honda Y, Kuroki Y, Shijubo N, Fujishima T, Takahashi H, Hosoda K, Akino T, Abe S : Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. Respiration 62 : 64-69, 1995
53. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S : Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 152 : 1860-1866, 1995
54. McCormack FX, King TE Jr, Voelker DR, Robinson PC, Mason RJ : Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 144 : 160-166, 1991